Sands Capital Management Has Decreased Its Regeneron Pharmaceuticals (REGN) Holding as Shares Declined; Amazon Com (AMZN) Holding Held by Filament Llc

June 17, 2018 - By Maria Brooks

Amazon.com, Inc. (NASDAQ:AMZN) Logo

Filament Llc increased its stake in Amazon Com Inc (AMZN) by 88.65% based on its latest 2018Q1 regulatory filing with the SEC. Filament Llc bought 375 shares as the company’s stock rose 5.80% while stock markets declined. The institutional investor held 798 shares of the consumer services company at the end of 2018Q1, valued at $1.15 million, up from 423 at the end of the previous reported quarter. Filament Llc who had been investing in Amazon Com Inc for a number of months, seems to be bullish on the $832.64B market cap company. The stock decreased 0.46% or $7.89 during the last trading session, reaching $1715.97. About 3.88 million shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 62.09% since June 17, 2017 and is uptrending. It has outperformed by 49.52% the S&P500. Some Historical AMZN News: 09/04/2018 – Amazon spent nearly $23 billion on R&D last year – more than any other U.S. company. It’s followed in spending by: ✅ Alphabet – $16.6 billion ✅ Intel – $13.1 billion ✅ Microsoft – $12.3 billion ✅ Apple – $11; 09/05/2018 – Ty Cox: Source Familiar With Details Of Amazon’s Tire Install Collaboration With Sears Confirms to Benzinga The Partnership…; 18/04/2018 – AMAZON PUBLISHES LETTER TO HOLDERS; 03/05/2018 – Amazon makes a formal offer to buy 60% of its main competitor in India; 24/05/2018 – The homebuilder’s new homes are Wi-Fi certified, making them perfect showrooms for Amazon’s smart home devices; 15/03/2018 – PLAINTIFF SAYS WALMART “ABRUPTLY” FIRED HIM IN RETALIATION FOR HIS WHISTLEBLOWING, INCLUDING A REPORT TO ITS U.S. E-COMMERCE CEO, IN JANUARY 2017; 07/03/2018 – Amazon says it’s aware that some Echo devices are creepily laughing at people and it’s working on a fix; 13/03/2018 – Facebook, Amazon handicapped as they follow China playbook; 06/03/2018 – Examining Amazon’s Ambitious 2018 (Video); 26/04/2018 – Amazon will increase the price of its annual Prime plan effective in May

Sands Capital Management Llc decreased its stake in Regeneron Pharmaceuticals (REGN) by 5.97% based on its latest 2018Q1 regulatory filing with the SEC. Sands Capital Management Llc sold 152,525 shares as the company’s stock declined 9.59% with the market. The institutional investor held 2.40M shares of the health care company at the end of 2018Q1, valued at $827.87M, down from 2.56M at the end of the previous reported quarter. Sands Capital Management Llc who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be less bullish one the $33.98B market cap company. The stock decreased 0.12% or $0.37 during the last trading session, reaching $315.3. About 751,767 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 35.54% since June 17, 2017 and is downtrending. It has underperformed by 48.11% the S&P500. Some Historical REGN News: 01/05/2018 – REGENERON AND SANOFI TO LOWER NET PRICE OF PRALUENT; 16/05/2018 – Sanofi’s Dupixent Drug Meets Endpoints for Atopic Dermatitis Treatment; 31/05/2018 – Clearside Biomedical Announces Positive Topline Results from Phase 2 Clinical Trial of CLS-TA Used with Eylea in Patients with; 22/04/2018 – DJ Regeneron Pharmaceuticals Inc, Inst Holders, 1Q 2018 (REGN); 29/03/2018 – Regeneron Closes Above 50-Day Moving Average: Technicals; 21/03/2018 – ALNYLAM PHARMACEUTICALS INC – ALNYLAM WILL LEVERAGE ITS RNAI THERAPEUTICS PLATFORM TO IDENTIFY COMPOUNDS DIRECTED TO TARGET; 21/03/2018 – Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis; 01/05/2018 – Regeneron and Sanofi to Lower Net Price of Praluent (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients; 31/05/2018 – CLEARSIDE BIOMEDICAL INC – SUPRACHOROIDAL CLS-TA USED TOGETHER WITH INTRAVITREAL EYLEA WAS GENERALLY WELL TOLERATED; 03/05/2018 – REGENERON PHARMACEUTICALS INC – QTRLY PRALUENT GLOBAL SALES $60 MLN VS $36 MLN

Among 33 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 11 have Buy rating, 1 Sell and 21 Hold. Therefore 33% are positive. Regeneron Pharmaceuticals Inc. had 127 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Friday, October 2. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Outperform” rating given on Friday, January 6 by RBC Capital Markets. Argus Research maintained it with “Buy” rating and $660 target in Thursday, August 6 report. Oppenheimer maintained the shares of REGN in report on Thursday, August 3 with “Hold” rating. The company was maintained on Thursday, February 8 by Guggenheim. The stock has “Outperform” rating by RBC Capital Markets on Thursday, November 5. The firm has “Hold” rating given on Thursday, November 9 by RBC Capital Markets. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) earned “Hold” rating by Cowen & Co on Monday, July 31. Robert W. Baird downgraded the stock to “Neutral” rating in Friday, August 5 report. As per Monday, June 12, the company rating was maintained by Leerink Swann.

Since February 9, 2018, it had 0 insider purchases, and 6 sales for $48.41 million activity. $680,000 worth of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares were sold by GOLDSTEIN JOSEPH L. STAHL NEIL had sold 11,407 shares worth $3.37M. 20,000 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares with value of $5.72 million were sold by SING GEORGE L.

Sands Capital Management Llc, which manages about $42.07 billion and $33.81B US Long portfolio, upped its stake in Intercontinental Exchange In (NYSE:ICE) by 57,165 shares to 172,551 shares, valued at $12.51 million in 2018Q1, according to the filing. It also increased its holding in Ctrip Com Intl Ltd (NASDAQ:CTRP) by 451,000 shares in the quarter, for a total of 2.58M shares, and has risen its stake in Allergan Plc.

Analysts await Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to report earnings on August, 2. They expect $4.39 earnings per share, up 13.14% or $0.51 from last year’s $3.88 per share. REGN’s profit will be $473.04 million for 17.96 P/E if the $4.39 EPS becomes a reality. After $3.98 actual earnings per share reported by Regeneron Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 10.30% EPS growth.

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Fool.com which released: “Should CRISPR Stock Investors Worry About Cancer?” on June 13, 2018, also Seekingalpha.com with their article: “Zoetis teams up with Regeneron to discover new vet treatments” published on June 06, 2018, Prnewswire.com published: “Regeneron’s Investigational Ebola Treatment Shipping to Democratic Republic of the Congo for Use in Current Outbreak” on May 31, 2018. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Streetinsider.com and their article: “Sanofi (SNY), Regeneron (REGN) Announce NEJM Published Pivotal Cemiplimab Trials showing Positive Results in …” published on June 04, 2018 as well as Gurufocus.com‘s news article titled: “Stocks That Fell to 3-Year Lows in the Week of May 25” with publication date: May 27, 2018.

Investors sentiment decreased to 1.05 in 2018 Q1. Its down 0.12, from 1.17 in 2017Q4. It fall, as 70 investors sold REGN shares while 158 reduced holdings. 71 funds opened positions while 169 raised stakes. 69.33 million shares or 0.23% more from 69.17 million shares in 2017Q4 were reported. Moreover, Pitcairn has 0.06% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 1,625 shares. New York State Teachers Retirement Systems, New York-based fund reported 120,167 shares. Franklin Inc accumulated 767,860 shares or 0.13% of the stock. Deutsche State Bank Ag holds 0.17% or 761,473 shares. Ubs Asset Mgmt Americas stated it has 341,092 shares. Dekabank Deutsche Girozentrale has invested 0.11% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Vident Investment Advisory Ltd Liability Corporation stated it has 0.03% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Tekla Cap Limited Liability accumulated 139,560 shares. Cornerstone Advsr Inc stated it has 3,000 shares. Massachusetts Services Ma has invested 0.05% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Howe & Rusling has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Mackenzie Financial holds 0% or 1,012 shares. Bancorp Of America De stated it has 0.07% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Aqr Capital Limited Liability Com accumulated 0.11% or 291,298 shares. Arrow Finance Corp holds 0% or 60 shares.

Among 55 analysts covering Amazon.com (NASDAQ:AMZN), 52 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 305 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, October 27 by SunTrust. RBC Capital Markets maintained the shares of AMZN in report on Friday, October 23 with “Outperform” rating. As per Monday, September 18, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Mizuho with “Buy” on Friday, September 23. Evercore maintained Amazon.com, Inc. (NASDAQ:AMZN) on Friday, March 9 with “Buy” rating. The company was maintained on Friday, February 2 by Stifel Nicolaus. The firm earned “Buy” rating on Friday, October 28 by Canaccord Genuity. On Wednesday, October 11 the stock rating was maintained by Canaccord Genuity with “Buy”. As per Friday, October 23, the company rating was maintained by JP Morgan. KeyBanc Capital Markets maintained the stock with “Hold” rating in Thursday, June 15 report.

Filament Llc, which manages about $1.34 billion and $278.13M US Long portfolio, decreased its stake in Ishares Core Us Aggrgt Bond Etf Iv (AGG) by 3,573 shares to 4,367 shares, valued at $468,000 in 2018Q1, according to the filing.

Investors sentiment decreased to 1.08 in Q1 2018. Its down 0.21, from 1.29 in 2017Q4. It is negative, as 73 investors sold AMZN shares while 659 reduced holdings. 173 funds opened positions while 614 raised stakes. 266.38 million shares or 4.87% less from 280.02 million shares in 2017Q4 were reported. Investec Asset Mgmt has 175,087 shares for 1.36% of their portfolio. 358 are owned by Horan Advisors Lc. Timber Creek Capital Management Ltd Liability Co stated it has 4.92% in Amazon.com, Inc. (NASDAQ:AMZN). Keybank Association Oh stated it has 172,530 shares. De Burlo Group invested 4.35% in Amazon.com, Inc. (NASDAQ:AMZN). Dumont Blake Investment Advisors, New Jersey-based fund reported 293 shares. New York-based Beech Hill Advsr has invested 2.72% in Amazon.com, Inc. (NASDAQ:AMZN). Pittenger Anderson Inc stated it has 1.25% in Amazon.com, Inc. (NASDAQ:AMZN). Wells Fargo And Mn reported 2.15M shares stake. Cue Fincl Grp Incorporated Inc holds 0.25% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 262 shares. Neuberger Berman Gru Ltd Company invested 0.47% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Dekabank Deutsche Girozentrale holds 162,937 shares. Centurylink Investment Management reported 5,578 shares stake. Wg Shaheen Dba Whitney has invested 0.17% in Amazon.com, Inc. (NASDAQ:AMZN). Oklahoma-based Bridgecreek Mgmt Llc has invested 4.11% in Amazon.com, Inc. (NASDAQ:AMZN).

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Seekingalpha.com which released: “Seattle council repeals ‘head tax'” on June 13, 2018, also Seekingalpha.com with their article: “Amazon slammed over factory conditions” published on June 11, 2018, Seekingalpha.com published: “The Proof That Amazon Is Undervalued” on May 23, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Seekingalpha.com and their article: “3 Option Trade Ideas In Amazon Stock” published on June 11, 2018 as well as Seekingalpha.com‘s news article titled: “Amazon’s “style assistant” camera now widely available” with publication date: June 06, 2018.

Since February 15, 2018, it had 0 insider purchases, and 21 insider sales for $63.19 million activity. On Thursday, February 15 the insider Blackburn Jeffrey M sold $18.50M. Another trade for 435 shares valued at $686,439 was made by Reynolds Shelley on Tuesday, May 15. The insider Zapolsky David sold $3.24M. Olsavsky Brian T had sold 2,333 shares worth $3.42M on Thursday, February 15. $2.17M worth of Amazon.com, Inc. (NASDAQ:AMZN) was sold by STONESIFER PATRICIA Q on Wednesday, May 2. Jassy Andrew R sold $2.90 million worth of Amazon.com, Inc. (NASDAQ:AMZN) on Thursday, February 15.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>